Persistent Asset Partners LTD Pacira Bio Sciences, Inc. Transaction History
Persistent Asset Partners LTD
- $135 Billion
- Q2 2025
A detailed history of Persistent Asset Partners LTD transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Persistent Asset Partners LTD holds 13,575 shares of PCRX stock, worth $304,623. This represents 0.24% of its overall portfolio holdings.
Number of Shares
13,575
Previous 8,963
51.46%
Holding current value
$304,623
Previous $223 Million
45.67%
% of portfolio
0.24%
Previous 0.19%
Shares
2 transactions
Others Institutions Holding PCRX
# of Institutions
260Shares Held
51.1MCall Options Held
289KPut Options Held
130K-
Black Rock Inc. New York, NY8.01MShares$180 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.41MShares$121 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.4MShares$53.8 Million0.08% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY2.25MShares$50.6 Million0.04% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.15MShares$48.3 Million0.01% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $1.03B
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...